Theodore R Schroeder, Chief Executive Officer

NBRV 648,818 shares

The estimated Net Worth of Theodore R Schroeder is at least $345,819.99. Theodore R Schroeder owns over 648,818 units of Nabriva Therapeutics Plc stock worth over $345,819.99.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
30th September 2020NBRV - Nabriva Therapeutics Plc1,211Payment by withholding648,818$0.53$645.46$345,819.99
25th April 2019COLL - Collegium Pharmaceutical, Inc.4,707Grant/award etc.6,960$0.00
25th July 2019NBRV - Nabriva Therapeutics Plc6,748Grant/award etc.67,489$0.00
27th August 2019NBRV - Nabriva Therapeutics Plc50,000Open or private purchase117,489$1.79$89,500.00$210,305.31
31st January 2020NBRV - Nabriva Therapeutics Plc16,276Payment by withholding302,760$1.35$21,972.60$408,726.00
6th February 2020NBRV - Nabriva Therapeutics Plc343,800Grant/award etc.646,560$0.00
28th February 2020NBRV - Nabriva Therapeutics Plc1,211Payment by withholding651,108$1.35$1,634.85$878,995.80
31st March 2020NBRV - Nabriva Therapeutics Plc1,211Payment by withholding649,897$0.58$696.32$373,690.77
30th April 2020NBRV - Nabriva Therapeutics Plc1,211Payment by withholding648,686$0.55$663.99$355,674.53
20th May 2020COLL - Collegium Pharmaceutical, Inc.4,047Grant/award etc.11,007$0.00
31st May 2020NBRV - Nabriva Therapeutics Plc1,211Payment by withholding653,662$1.14$1,380.54$745,174.68
30th June 2020NBRV - Nabriva Therapeutics Plc1,211Payment by withholding652,451$0.67$816.94$440,143.44
31st July 2020NBRV - Nabriva Therapeutics Plc1,211Payment by withholding651,240$0.76$920.36$494,942.40
31st August 2020NBRV - Nabriva Therapeutics Plc1,211Payment by withholding650,029$0.62$750.09$402,627.96